Amgen Inc.
170.683.01 (1.80%)

After hours: 169.39-1.29 (-0.76%) as of 7:58 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close167.67
Bid169.39 x 200
Ask170.50 x 800
52wk Range130.09 - 181.81
Day's Range167.44 - 171.08
Avg Vol (3m)2,837,088
As of 4:00 PM EDT. Market closed.
  • Associated Press4 hours ago

    Amgen tops Street 2Q forecasts

    Amgen Inc. (AMGN) on Wednesday reported second-quarter profit of $1.87 billion. On a per-share basis, the Thousand Oaks, California-based company said it had profit of $2.47. Earnings, adjusted for non-recurring ...

  • Reuters5 hours ago

    Amgen again raises 2016 forecast in display of confidence

    Amgen Inc on Wednesday posted higher-than-expected second-quarter profit on strong drug sales and again raised its full-year forecast in a clear signal of management confidence in the business. The company is on track to meet or exceed its long-term objectives, Chief Executive Robert Bradway said in a statement. Amgen, the world's largest biotechnology company by market value, now expects 2016 adjusted earnings of $11.10 to $11.40 per share, up from its prior view of $10.85 to $11.20.